![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » White House Seeks FDA Budget Increase for Fiscal 2021
White House Seeks FDA Budget Increase for Fiscal 2021
![WhiteHouse.gif](https://www.fdanews.com/ext/resources/test/WhiteHouse.gif?t=1581355320&width=430)
February 18, 2020
The Trump administration’s fiscal 2021 budget proposal seeks an increase of 4.5 percent for the FDA while cutting most other non-defense spending.
The $6.2 billion FDA budget request represents a substantial increase on the agency’s FY 2020 enacted budget, including $3.3 billion in appropriations and $2.9 billion in user fees.
By comparison, HHS, the FDA’s parent, would suffer a 10 percent across-the-board cut, according to the budget request.
The budget calls for $45 million for opioid enforcement activities at international mailing facilities and an additional $4.5 million to strengthen the quality of compounded drugs.
Upcoming Events
-
21Oct